Global Diabetic Retinopathy Market Report By Type (Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy) By Management (Anti-VEGF, Intraocular Steroid Injection, Laser Surgery, Vitrectomy) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2023-2032
The global demand for Diabetic Retinopathy Market is presumed to reach the market size of nearly USD 15.44 Billion by 2032 from USD 8.1 Billion in 2023 with a CAGR of 7.43% under the study period 2024 - 2032.
Diabetic retinopathy is an eye disease linked to diabetes, impacting the retina—the light-sensitive tissue at the back of the eye. It stands as a prominent cause of vision impairment among individuals with diabetes. The condition develops gradually as elevated levels of blood sugar associated with diabetes cause damage to the small blood vessels within the retina.
The diabetic retinopathy market is driven by several key factors, with the increasing global prevalence of diabetes being a primary contributor. As diabetes remains a significant health concern, the rising incidence contributes to a growing population at risk of diabetic retinopathy, propelling the demand for diagnostic and treatment solutions. The pivotal role of technological advancements in diagnostic tools and imaging techniques is evident in their contribution to enhancing early detection capabilities. The emphasis on regular eye screenings and the integration of telemedicine in screening programs further expands accessibility, particularly in underserved areas. Pharmaceutical innovations, including intravitreal injections and medications targeting diabetic macular edema, contribute to the market's development by offering effective management options. The heightened awareness among healthcare professionals and patients about the importance of eye health in diabetes management encourages increased screenings and early intervention.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of diabetic retinopathy. The growth and trends of diabetic retinopathy industry provide a holistic approach to this study.
This section of the diabetic retinopathy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
Proliferative Diabetic Retinopathy
Non-Proliferative Diabetic Retinopathy
Intraocular Steroid Injection
This section covers the regional outlook, which accentuates current and future demand for the Diabetic Retinopathy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Diabetic Retinopathy Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Diabetic Retinopathy market include Bayer AG, ABBVIE INC., Novartis AG, Oxurion NV, Sirnaomics, Alimera Sciences, Ampio Pharmaceuticals Inc., BCNPeptides, Kowa Company Ltd., and Genentech, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . DIABETIC RETINOPATHY – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Type
3.7.2 Market Attractiveness Analysis By Management
3.7.3 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL DIABETIC RETINOPATHY MARKET ANALYSIS BY TYPE
5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Proliferative Diabetic Retinopathy Historic and Forecast Sales by Regions
5.5 Non-proliferative Diabetic Retinopathy Historic and Forecast Sales by Regions
6 . GLOBAL DIABETIC RETINOPATHY MARKET ANALYSIS BY MANAGEMENT
6.1 Overview by Management
6.2 Historical and Forecast Data
6.3 Analysis by Management
6.4 Anti-VEGF Historic and Forecast Sales by Regions
6.5 Intraocular Steroid Injection Historic and Forecast Sales by Regions
6.6 Laser Surgery Historic and Forecast Sales by Regions
6.7 Vitrectomy Historic and Forecast Sales by Regions
7 . GLOBAL DIABETIC RETINOPATHY MARKET ANALYSIS BY GEOGRAPHY
Frequently Asked Questions (FAQs) about this Report
For the year 2023, the global market size for Diabetic Retinopathy Market was valued at USD 8.1 Billion.
The Global Diabetic Retinopathy Market growth is estimated to be close to 7.43% between 2024 and 2032.
In the Global Diabetic Retinopathy Market, North America holds the largest market share.
The Global Diabetic Retinopathy Market is segmented By Type (Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy) By Management (Anti-VEGF, Intraocular Steroid Injection, Laser Surgery, Vitrectomy) .
The leading players in the Global Diabetic Retinopathy Market are Bayer AG, ABBVIE INC., Novartis AG, Oxurion NV, Sirnaomics, Alimera Sciences, Ampio Pharmaceuticals Inc., BCNPeptides, Kowa Company Ltd., Genentech Inc. .